011HO15284 ALTASTEALTH

Print/PDF
Registration Name SHILOH-USA STEALTH-ET
Registration Number HO840003201522153
Primary NAAB Code 011HO15284
Secondary Code(s) 593HO15284, 611HO15284, 581HO15284, 511HO15284, 122HO15284
Status Inactive
Controller Name Alta Genetics (11)
Date of Birth 5/15/2019
aAa 342
DMS 345,135
GFI 11.9%
Genetic Codes * TL TR TD TC TP TY TV TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5C, HH6T
Sire PEAK ALTAHOTJOB-ET
MGS BLUMENFELD JEDI RESOLVE-ET
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin AB
INDEXES
NM$ 523, 92% R CM$ 521
NM Percentile 61% FM$ 528
GTPI 2967 GM$ 461
PRODUCTION TRAITS
3185 Dtrs 459 herds 45 % US 99% R
Milk 1469 Fat, % 46 , -0.05%
SCS 2.94, 98% R Protein, % 42 , -0.02%
Feed Saved -11 , 65% R Milking Speed 7.51 , 95% R
Health & Fertility
Productive Life 2.3      95% R Mastitis 0.3      89% R
Heifer Livability 0.2       80% R Metritis 0.9      85% R
Livability 1.8      83% R D. Abom 0.2      93% R
DPR -1.5      95% R Ketosis 2.5      84% R
HCR -1.4      94% R R. Placenta 0.6      88% R
CCR -1.7      95% R Milk Fever 0.0      73% R
SCR -        -
Calving Traits
Sire CE 1.0      97% R 4529 Obs
Daughter CE 1.3      93% R 720 Obs, 1392 Dtrs
Sire SB 3.1      95% R 6303 Obs
Daughter SB 2.8      92% R 627 Obs, Dtrs
Gestation Length -1.4      99% R 112 Obs, 2015 Dtrs
Early First Calving 1.2      92% R 96 Obs, 1091 Dtrs

CDCB August 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2025
830 Dtrs 167 herds 95% R
PTA Type 0.64 UDC 0.56
FLC 0.48 BWC 0.64
Linear Traits
Stature -0.41
Short
Strength 0.43
Weak
Body Depth -0.28
Shallow
Dairy Form -1.10
Closed
Rump Angle -1.52
Flat
Thurl Width -0.40
Narrow
Rear Legs-Side View -1.33
Straight
Rear Legs-Rear View 0.54
Straight
Foot Angle 1.00
Steep
Feet & Legs Score 0.31
High
F.U. Attachment 1.19
Strong
Rear Udder Height 0.60
High
Rear Udder Width -0.02
Narrow
Udder Cleft 0.48
Strong
Udder Depth 0.48
Shallow
Front Teat Placement -0.41
Wide
Rear Teat Placement -0.10
Wide
Teat Length 0.69
Long
-2
0
2

CDCB August 2025; Base of Evaluation: HO